Matches in Wikidata for { <http://www.wikidata.org/entity/Q93191277> ?p ?o ?g. }
Showing items 1 to 43 of
43
with 100 items per page.
- Q93191277 description "artículu científicu espublizáu en setiembre de 2018" @default.
- Q93191277 description "scientific article published on 29 September 2018" @default.
- Q93191277 description "wetenschappelijk artikel" @default.
- Q93191277 description "наукова стаття, опублікована у вересні 2018" @default.
- Q93191277 name "Direct oral anticoagulants for the treatment of venous thromboembolism in cancer patients: Potential for drug-drug interactions" @default.
- Q93191277 name "Direct oral anticoagulants for the treatment of venous thromboembolism in cancer patients: Potential for drug-drug interactions" @default.
- Q93191277 type Item @default.
- Q93191277 label "Direct oral anticoagulants for the treatment of venous thromboembolism in cancer patients: Potential for drug-drug interactions" @default.
- Q93191277 label "Direct oral anticoagulants for the treatment of venous thromboembolism in cancer patients: Potential for drug-drug interactions" @default.
- Q93191277 prefLabel "Direct oral anticoagulants for the treatment of venous thromboembolism in cancer patients: Potential for drug-drug interactions" @default.
- Q93191277 prefLabel "Direct oral anticoagulants for the treatment of venous thromboembolism in cancer patients: Potential for drug-drug interactions" @default.
- Q93191277 P1433 Q93191277-12C58532-E505-4056-9628-A1FA75822BE5 @default.
- Q93191277 P1476 Q93191277-D0AF08DF-9561-4F06-9585-DD97FF4C3AA4 @default.
- Q93191277 P2093 Q93191277-19780904-6252-4CF8-91A5-1617ACDD7B75 @default.
- Q93191277 P2093 Q93191277-2975B306-2E66-41B5-AF70-5B2F0B8520AC @default.
- Q93191277 P2093 Q93191277-5667153C-5D6A-4231-A95C-F9909B47B34D @default.
- Q93191277 P2093 Q93191277-DD742F3D-D401-495D-A026-68899A339292 @default.
- Q93191277 P2093 Q93191277-F8C7CEE8-4B6A-4DDB-BBC1-405A01676553 @default.
- Q93191277 P304 Q93191277-38E7F074-C0C5-4075-8EDA-EF6B50CFCAED @default.
- Q93191277 P31 Q93191277-FE88EF36-3B14-436E-81EF-DD6BBCA45846 @default.
- Q93191277 P356 Q93191277-627028A3-652E-4B17-8800-A1DA8BC4BBFD @default.
- Q93191277 P478 Q93191277-DDDE9DDD-003B-456B-843D-00456C08173D @default.
- Q93191277 P577 Q93191277-74BAC850-5314-4003-974F-6D3CCFA45924 @default.
- Q93191277 P698 Q93191277-619A18D0-B011-469C-9DC1-050A522B4103 @default.
- Q93191277 P921 Q93191277-36738A83-D3AB-465D-954C-76915DEF53B4 @default.
- Q93191277 P921 Q93191277-BC42B6FE-E033-4CEA-BE32-22D952B63CAA @default.
- Q93191277 P356 J.CRITREVONC.2018.09.015 @default.
- Q93191277 P698 30447923 @default.
- Q93191277 P1433 Q15724423 @default.
- Q93191277 P1476 "Direct oral anticoagulants for the treatment of venous thromboembolism in cancer patients: Potential for drug-drug interactions" @default.
- Q93191277 P2093 "Hanno Riess" @default.
- Q93191277 P2093 "Paolo Prandoni" @default.
- Q93191277 P2093 "Rupert Bauersachs" @default.
- Q93191277 P2093 "Sebastian Harder" @default.
- Q93191277 P2093 "Stephan Kreher" @default.
- Q93191277 P304 "169-179" @default.
- Q93191277 P31 Q13442814 @default.
- Q93191277 P356 "10.1016/J.CRITREVONC.2018.09.015" @default.
- Q93191277 P478 "132" @default.
- Q93191277 P577 "2018-09-29T00:00:00Z" @default.
- Q93191277 P698 "30447923" @default.
- Q93191277 P921 Q718753 @default.
- Q93191277 P921 Q9397786 @default.